Coverage
-
August 11, 2020
A Massachusetts federal judge paused a proposed class action over the potency of CBD supplement products Tuesday, following three other federal courts in saying the suit can wait until the U.S. Food and Drug Administration releases long-awaited rules regulating the popular hemp-derived compound.
4 other articles on this case.
View all »